Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $141,486 - $201,825
-34,678 Reduced 6.75%
479,124 $2.62 Million
Q2 2022

Aug 15, 2022

SELL
$4.15 - $8.37 $1.09 Million - $2.2 Million
-262,251 Reduced 33.79%
513,802 $2.32 Million
Q1 2022

May 16, 2022

SELL
$5.91 - $14.38 $5.21 Million - $12.7 Million
-881,994 Reduced 53.19%
776,053 $5.72 Million
Q4 2021

Feb 14, 2022

BUY
$5.21 - $8.61 $730,666 - $1.21 Million
140,243 Added 9.24%
1,658,047 $10.7 Million
Q3 2021

Nov 12, 2021

BUY
$4.45 - $10.63 $629,372 - $1.5 Million
141,432 Added 10.28%
1,517,804 $8.83 Million
Q2 2021

Aug 13, 2021

BUY
$8.11 - $11.11 $4.43 Million - $6.07 Million
546,691 Added 65.89%
1,376,372 $14.2 Million
Q1 2021

May 17, 2021

BUY
$9.85 - $17.69 $8.17 Million - $14.7 Million
829,681 New
829,681 $8.73 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.